TABLE 1.
Effect and CI of Combination Treatment of Irinotecan and EGCG in RKO Cell
| Dose IRI (µmol L−) | Dose EGCG (µmol L−) | Effect | CI |
|---|---|---|---|
| 0.5 | 10.0 | 0.46801 | 0.5737 |
| 0.5 | 20.0 | 0.50291 | 0.6497 |
| 0.5 | 50.0 | 0.61924 | 0.5568 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.